Seer, Inc. (SEER) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2023)
SEER's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
SEER Revenue Analysis (2018–2024)
As of March 4, 2026, Seer, Inc. (SEER) generated trailing twelve-month (TTM) revenue of $16.3 million, reflecting modest growth of +4.5% year-over-year. The most recent quarter (Q3 2025) recorded $4.1 million in revenue, up 1.7% sequentially.
Looking at the longer-term picture, SEER's 5-year compound annual growth rate (CAGR) stands at +160.6%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $15.2 million in 2023.
Revenue diversification analysis shows SEER's business is primarily driven by Grant (100%). With over half of revenue concentrated in Grant, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CAI (+144.9% YoY), VCYT (+16.0% YoY), and ADPT (+42.6% YoY), SEER has underperformed the peer group in terms of revenue growth. Compare SEER vs CAI →
Peer Comparison
Compare SEER's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SEERCurrent | $16M | +4.5% | +160.6% | -717.7% | |
 CAI | $812M | +144.9% | +14.3% | 5.6% | |
 VCYT | $517M | +16.0% | +34.5% | 11.2% | |
 ADPT | $179M | +42.6% | +16.0% | -90.8% | |
 YDES | $510,360 | - | - | -286.5% | |
 IMDX | $2M | +520.9% | - | -3245.1% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $13.9M | -8.1% | $6.8M | 49.0% | $-100,101,000 | -717.7% |
| 2023 | $15.2M | +3.4% | $1.4M | 9.5% | $-104,942,000 | -691.2% |
| 2022 | $14.7M | +129.7% | $384K | 2.6% | $-98,043,000 | -667.6% |
| 2021 | $6.4M | +874.7% | $-374,000 | -5.8% | $-71,696,000 | -1121.3% |
| 2020 | $656K | +465.5% | $-950,000 | -144.8% | $-33,649,000 | -5129.4% |
| 2019 | $116K | - | $-585,000 | -504.3% | $-16,883,000 | -14554.3% |
| 2018 | $0 | - | $-100,000 | - | $-6,758,000 | - |
See SEER's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SEER Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SEER vs AGIO
See how SEER stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SEER's revenue growth accelerating or slowing?
SEER revenue growth slowed to +4.5%, below the 5-year CAGR of +160.6%. TTM revenue is $16M. The deceleration marks a shift from historical growth rates.
What is SEER's long-term revenue growth rate?
Seer, Inc.'s 5-year revenue CAGR of +160.6% reflects the variable expansion pattern. Current YoY growth of +4.5% is near this long-term average.
How is SEER's revenue distributed by segment?
SEER reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.